- $3.13bn
- $8.42bn
- $3.63bn
Annual balance sheet for Marex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 January 1st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F | 6-K |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,511 | 9,737 | 9,806 | 10,386 | 12,590 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,029 | 4,675 | 4,770 | 7,533 | 11,021 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,125 | 15,354 | 16,936 | 23,829 | 33,697 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 24.9 | 45.5 | 57.2 | 80.7 | 111 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,265 | 15,744 | 17,612 | 24,313 | 34,675 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,630 | 14,562 | 15,885 | 21,779 | 30,963 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,787 | 15,066 | 16,836 | 23,336 | 33,411 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 478 | 678 | 776 | 977 | 1,264 |
| Total Liabilities & Shareholders' Equity | 5,265 | 15,744 | 17,612 | 24,313 | 34,675 |
| Total Common Shares Outstanding |